Celgene: Growth At A Reasonable Price Even On Revised Guidance

Introduction This article is an update to my original article on Celgene (CELG) published on June 22, 2017.  Celgene reported their financial results yesterday October 26, 2017, and although the quarter was good, lowered guidance crushed the stock price.  In my opinion, some of the sag in price was justified, but for the most part Read more about Celgene: Growth At A Reasonable Price Even On Revised Guidance[…]